Tempus AI

Tempus AI, Inc. (NASDAQ: TEM) is a technology company headquartered in Chicago, Illinois, that applies artificial intelligence to precision medicine. The company maintains an extensive library of clinical and molecular data designed to support data-driven treatment decisions at the point of care.

The Tempus platform integrates multimodal datasets — including genomic, clinical and imaging information — to generate insights across medical specialties such as oncology, cardiology and neurology. Core offerings include genomic sequencing, AI-powered diagnostic tools and clinical trial matching services.

Tempus works with academic medical centers, community hospitals and pharmaceutical companies to advance the use of data science in healthcare. Its genomic profiling services help clinicians identify targeted therapies based on a patient's molecular profile, while its data licensing business provides de-identified datasets to researchers and drug developers.

The company operates through two primary segments: Genomics, which delivers sequencing and diagnostic services, and Data and Services, which encompasses its AI applications and data partnerships. Tempus aims to make precision medicine accessible across a broader range of clinical settings by reducing the complexity of interpreting large-scale biological data.